Copyright Reports & Markets. All rights reserved.

Global Neglected Tropical Diseases Drugs and Vaccine Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Neglected Tropical Diseases Drugs and Vaccine Market Overview

    • 1.1 Product Overview and Scope of Neglected Tropical Diseases Drugs and Vaccine
    • 1.2 Classification of Neglected Tropical Diseases Drugs and Vaccine by Types
      • 1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Types in 2018
      • 1.2.3 Malaria
      • 1.2.4 Ebola
      • 1.2.5 Dengue
      • 1.2.6 Chagas
      • 1.2.7 Leishmaniasis
      • 1.2.8 Other
    • 1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market by Application
      • 1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Drugs
      • 1.3.3 Vaccines
    • 1.4 Global Neglected Tropical Diseases Drugs and Vaccine Market by Regions
      • 1.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Neglected Tropical Diseases Drugs and Vaccine Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Neglected Tropical Diseases Drugs and Vaccine Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neglected Tropical Diseases Drugs and Vaccine Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Neglected Tropical Diseases Drugs and Vaccine Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neglected Tropical Diseases Drugs and Vaccine Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Neglected Tropical Diseases Drugs and Vaccine (2014-2024)

    2 Company Profiles

    • 2.1 Artecef BV
      • 2.1.1 Business Overview
      • 2.1.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Macleods Pharmaceuticals
      • 2.2.1 Business Overview
      • 2.2.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Novartis
      • 2.3.1 Business Overview
      • 2.3.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 GlaxoSmithKline
      • 2.4.1 Business Overview
      • 2.4.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Lupin
      • 2.5.1 Business Overview
      • 2.5.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 AstraZeneca
      • 2.6.1 Business Overview
      • 2.6.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Romark Laboratories
      • 2.7.1 Business Overview
      • 2.7.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Ranbaxy Labs
      • 2.8.1 Business Overview
      • 2.8.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Sanofi-Aventis
      • 2.9.1 Business Overview
      • 2.9.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Cipla
      • 2.10.1 Business Overview
      • 2.10.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Toyama Chemica
      • 2.11.1 Business Overview
      • 2.11.2 Neglected Tropical Diseases Drugs and Vaccine Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Neglected Tropical Diseases Drugs and Vaccine Market Competition, by Players

    • 3.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Neglected Tropical Diseases Drugs and Vaccine Players Market Share
      • 3.2.2 Top 10 Neglected Tropical Diseases Drugs and Vaccine Players Market Share
    • 3.3 Market Competition Trend

    4 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions

    • 4.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue and Market Share by Regions
    • 4.2 North America Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 4.5 South America Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)

    5 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Countries

    • 5.1 North America Neglected Tropical Diseases Drugs and Vaccine Revenue by Countries (2014-2019)
    • 5.2 USA Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)

    6 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Countries

    • 6.1 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue by Countries (2014-2019)
    • 6.2 Germany Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 6.3 UK Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 6.4 France Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Revenue by Countries

    • 7.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Revenue by Countries (2014-2019)
    • 7.2 China Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 7.5 India Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)

    8 South America Neglected Tropical Diseases Drugs and Vaccine Revenue by Countries

    • 8.1 South America Neglected Tropical Diseases Drugs and Vaccine Revenue by Countries (2014-2019)
    • 8.2 Brazil Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Neglected Tropical Diseases Drugs and Vaccine by Countries

    • 9.1 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Neglected Tropical Diseases Drugs and Vaccine Revenue and Growth Rate (2014-2019)

    10 Global Neglected Tropical Diseases Drugs and Vaccine Market Segment by Type

    • 10.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Type (2019-2024)
    • 10.3 Malaria Revenue Growth Rate (2014-2024)
    • 10.4 Ebola Revenue Growth Rate (2014-2024)
    • 10.5 Dengue Revenue Growth Rate (2014-2024)
    • 10.6 Chagas Revenue Growth Rate (2014-2024)
    • 10.7 Leishmaniasis Revenue Growth Rate (2014-2024)
    • 10.8 Other Revenue Growth Rate (2014-2024)

    11 Global Neglected Tropical Diseases Drugs and Vaccine Market Segment by Application

    • 11.1 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2014-2019)
    • 11.2 Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Application (2019-2024)
    • 11.3 Drugs Revenue Growth (2014-2019)
    • 11.4 Vaccines Revenue Growth (2014-2019)

    12 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast (2019-2024)

    • 12.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast (2019-2024)
    • 12.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Regions (2019-2024)
    • 12.3 North America Neglected Tropical Diseases Drugs and Vaccine Revenue Market Forecast (2019-2024)
    • 12.4 Europe Neglected Tropical Diseases Drugs and Vaccine Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Revenue Market Forecast (2019-2024)
    • 12.6 South America Neglected Tropical Diseases Drugs and Vaccine Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Description

      Scope of the Report:
      The global Neglected Tropical Diseases Drugs and Vaccine market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neglected Tropical Diseases Drugs and Vaccine.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Neglected Tropical Diseases Drugs and Vaccine market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neglected Tropical Diseases Drugs and Vaccine market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Artecef BV
      Macleods Pharmaceuticals
      Novartis
      GlaxoSmithKline
      Lupin
      AstraZeneca
      Romark Laboratories
      Ranbaxy Labs
      Sanofi-Aventis
      Cipla
      Toyama Chemica

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Malaria
      Ebola
      Dengue
      Chagas
      Leishmaniasis
      Other

      Market Segment by Applications, can be divided into
      Drugs
      Vaccines
      Buy now